Effect of Liraglutide on Heart Frequency in Healthy Volunteers

Inclusion Criteria: * Healthy * Fasting plasma glucose within normal limits (80-100 mg/dl) * BMI (Body Mass Index): 20.0-29.0 kg/m\^2 (inclusive) * Heart rate within the range of 50-90 beats per minute (inclusive) * Subject is judged to be in good health on the basis of their medical history, physical examination, ECG (electrocardiogram), and routine laboratory data Exclusion Criteria: * Any clinically significant disease history, in the opinion of the investigator, of systemic or organ disease * Any clinically significant disease history, in the opinion of the investigator, of cardiovascular disease * Clinically significant abnormalities on any pre-study clinical examination or any abnormal laboratory measurements during screening * A family history of sudden cardiac death at age less than 50 years old * T-wave abnormalities * Individual or familial history of long QT Syndrome * Positive results on Screening for Hepatitis B surface antigen, Hepatitis C antibody or HIV (human immunodeficiency virus) antibody * Positive results on the urine drug and alcohol screen * Any regular use of prescription or nonprescription drugs or vitamins and herbal/nutritional supplements that cannot be stopped at screening * Any strenuous exercise (as judged by the investigator) from 4 days prior to randomisation and during the entire trial period * Blood donation, trauma or surgery with blood loss exceeding 500 ml within the last 2 months prior to dosing * Subject is a smoker, occasional smoker or has a history of smoking (or use of any tobacco) within the last 3 months * Excessive use of methylxanthine-containing beverages (more than 8 cups/day of coffee, tea, soda or chocolate) * Females who are pregnant, breastfeeding, intend to become pregnant within the next 3 months, or who are judged to be using inadequate contraceptive measures * A history (within the last 2 years) of drug or alcohol abuse